MESQUITE, Texas, Dec. 16, 2025 /PRNewswire/ — MPM Medical today announced a major expansion of its U.S. manufacturing capabilities with the acquisition of a full collagen manufacturing platform and the associated FDA 510(k) clearance for surgical collagen devices. This expansion significantly enhances MPM Medical’s ability to serve advanced wound care, surgical, and private-label partners with high-quality, American-made collagen products.

This announcement follows last week’s national press release introducing MPM Medical’s Collagen At-Home Wound Care Kits and Proprietary Wound Care Portal, reinforcing the company’s strategy to expand both its digital and manufacturing infrastructure in support of clinicians, health systems, and patients nationwide.